FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 9th, 2025 � HCW Biologics Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [_____], 2025, between HCW Biologics Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 8th, 2025 � Theriva Biologics, Inc. � Pharmaceutical preparations � New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement�) is dated as of May 7, 2025, between Theriva Biologics, Inc., a Nevada corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 7th, 2025 � Pasithea Therapeutics Corp. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of May 6, 2025, between Pasithea Therapeutics Corp., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 7th, 2025 � authID Inc. � Services-prepackaged software � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of May 6, 2025, between authID Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 5th, 2025 � bioAffinity Technologies, Inc. � Services-commercial physical & biological research � New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement�) is entered into and made effective as of [*], 2025, by and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 2nd, 2025 � bioAffinity Technologies, Inc. � Services-commercial physical & biological research � New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement�) is entered into and made effective as of [*], 2025, by and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � May 1st, 2025 � Pasithea Therapeutics Corp. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [__], 2025, between Pasithea Therapeutics Corp., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 28th, 2025 � Lexaria Bioscience Corp. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 24, 2025, between Lexaria Bioscience Corp., a Nevada corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 25th, 2025 � Silo Pharma, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of ______, 2025, between Silo Pharma, Inc., a Nevada corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 22nd, 2025 � Aptevo Therapeutics Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 21, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively, the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 22nd, 2025 � Fly-E Group, Inc. � Motor vehicles & passenger car bodies � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [●], 2025, by and among Fly-E Group, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 17th, 2025 � Mangoceuticals, Inc. � Services-misc health & allied services, nec � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 11, 2025 between Mangoceuticals, Inc. (the “Corporation� or “Company�), a corporation organized under the laws of the State of Texas (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 11th, 2025 � Bio-Path Holdings, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [ ], 2025, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 11th, 2025 � Venus Concept Inc. � Surgical & medical instruments & apparatus � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 9, 2025, between Venus Concept Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 9th, 2025 � Immunic, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 9, 2025, between Immunic, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 4th, 2025 � Imunon, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [____], 2025, between Imunon, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 3rd, 2025 � Sunshine Biopharma Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 2, 2025, between Sunshine Biopharma Inc., a Colorado corporation (the “Company�), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser� and collectively, the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 2nd, 2025 � Citius Pharmaceuticals, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 1, 2025, between Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 2nd, 2025 � GRI Bio, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of April 1, 2025, between GRI Bio, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � April 1st, 2025 � Surf Air Mobility Inc. � Air transportation, nonscheduled � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of March 31, 2025, between Surf Air Mobility Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � March 25th, 2025 � Bridgeline Digital, Inc. � Services-prepackaged software � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of March 24, 2025, between Bridgeline Digital, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � March 25th, 2025 � Aptevo Therapeutics Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of ______, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively, the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � March 18th, 2025 � Castellum, Inc. � Services-management consulting services � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of March 16, 2025 between Castellum, Inc., a Nevada corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � March 4th, 2025 � BioXcel Therapeutics, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of March 3, 2025, between BioXcel Therapeutics, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � March 3rd, 2025 � Aptevo Therapeutics Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of ______, 2025, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively, the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 21st, 2025 � Allurion Technologies, Inc. � Surgical & medical instruments & apparatus � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of February 19, 2025, between Allurion Technologies, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 21st, 2025 � Petros Pharmaceuticals, Inc. � Pharmaceutical preparations � New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement�) is entered into and made effective as of February 17, 2025, between Petros Pharmaceuticals, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 20th, 2025 � Precision Optics Corporation, Inc. � Electromedical & electrotherapeutic apparatus � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of February19, 2025, between Precision Optics Corporation, Inc., a Massachusetts corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively, the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 19th, 2025 � Predictive Oncology Inc. � Orthopedic, prosthetic & surgical appliances & supplies � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of February 18, 2025, between Predictive Oncology Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 18th, 2025 � Digital Brands Group, Inc. � Retail-apparel & accessory stores � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [●], 2025, between Digital Brands Group Inc., a company incorporated under the laws of Delaware (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 13th, 2025 � Wisa Technologies, Inc. � Semiconductors & related devices � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of February 13, 2025, between WiSA Technologies, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 13th, 2025 � ReShape Lifesciences Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of February [•], 2025, between ReShape Lifesciences Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 12th, 2025 � Bio-Path Holdings, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [ ], 2025, between Bio-Path Holdings, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 11th, 2025 � Moleculin Biotech, Inc. � Pharmaceutical preparations � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of [______], 2025, between Moleculin Biotech, Inc., a Delaware corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement � February 10th, 2025 � Oncocyte Corp � In vitro & in vivo diagnostic substances � New York
This Securities Purchase Agreement (this “Agreement�) is dated as of February 7, 2025 between Oncocyte Corporation, a California corporation (the “Company�), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser� and collectively the “Purchasers�).